Research-In-Progress: "Antibody Blockade of Activin Type II Receptors Preserves Skeletal Muscle Mass and Enhances Fat Loss During GLP-1 Receptor Agonism."
Speaker: Libby Nunn (Titchenell Lab)
Sorry, your browser is out of date
The web browser you are using is too old to view this site. Please update your browser or use Internet Explorer 11 or the current version of Microsoft Edge, Firefox, Chrome or Safari. Thank you!
